James F Oliviero III Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James F Oliviero III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James F Oliviero III. James F Oliviero III is Chief Financial Officer in KERYX BIOPHARMACEUTICALS INC ($KERX) and Vice President Finance in KERYX BIOPHARMACEUTICALS INC ($KERX) and Vice President, Finance in KERYX BIOPHARMACEUTICALS INC ($KERX) and CEO and President in Checkpoint Therapeutics, Inc. ($CKPT) and CEO, President and Director in Checkpoint Therapeutics, Inc. ($CKPT).
Latest Insider Trading Transactions of James F Oliviero III
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Sell | S | 3.42 | 48,790 | 166,745 | 3,153,210 | 3.2 M to 3.2 M (-1.52 %) |
| Feb 05 2021 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Sell | S | 3.51 | 70,000 | 245,525 | 3,202,000 | 3.3 M to 3.2 M (-2.14 %) |
| Feb 25 2020 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Grant | A | 0.00 | 598,000 | 0 | 2,733,000 | 2.1 M to 2.7 M (+28.01 %) |
| Jan 25 2019 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Grant | A | 0.00 | 485,000 | 0 | 2,135,000 | 1.7 M to 2.1 M (+29.39 %) |
| Feb 01 2018 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO and President | Grant | A | 0.00 | 325,000 | 0 | 1,650,000 | 1.3 M to 1.7 M (+24.53 %) |
| Dec 19 2016 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO and President | Grant | A | 0.00 | 325,000 | 0 | 1,325,000 | 1000 K to 1.3 M (+32.50 %) |
| Jul 08 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 9.61 | 1,943 | 18,672 | 209,406 | 211.3 K to 209.4 K (-0.92 %) |
| May 12 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | M | 2.78 | 23,278 | 64,713 | 13,966 | |
| May 12 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | M | 2.53 | 18,333 | 46,382 | 0 | |
| May 12 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 2.78 | 23,278 | 64,713 | 211,349 | 188.1 K to 211.3 K (+12.38 %) |
| May 12 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 2.53 | 18,333 | 46,382 | 188,071 | 169.7 K to 188.1 K (+10.80 %) |
| Apr 08 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 11.68 | 1,878 | 21,935 | 169,738 | 171.6 K to 169.7 K (-1.09 %) |
| Jan 06 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | A | 14.34 | 47,750 | 684,735 | 47,750 | |
| Jan 06 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 13.79 | 5,604 | 77,279 | 171,616 | 177.2 K to 171.6 K (-3.16 %) |
| Jan 06 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 23,875 | 0 | 177,220 | 153.3 K to 177.2 K (+15.57 %) |
| Dec 12 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 15.69 | 25,000 | 392,250 | 153,345 | 178.3 K to 153.3 K (-14.02 %) |
| Dec 12 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 11.22 | 25,000 | 280,500 | 178,345 | 153.3 K to 178.3 K (+16.30 %) |
| Oct 07 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 16.14 | 2,694 | 43,481 | 153,345 | 156 K to 153.3 K (-1.73 %) |
| Oct 07 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 16.14 | 2,694 | 43,481 | 153,345 | 156 K to 153.3 K (-1.73 %) |
| Sep 10 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 15.88 | 144,237 | 2,290,484 | 156,039 | 300.3 K to 156 K (-48.03 %) |
| Jul 09 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 15.75 | 2,054 | 32,351 | 300,276 | 302.3 K to 300.3 K (-0.68 %) |
| Apr 07 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 16.46 | 2,087 | 34,352 | 302,330 | 304.4 K to 302.3 K (-0.69 %) |
| Mar 21 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 15.11 | 13,444 | 203,139 | 304,417 | 317.9 K to 304.4 K (-4.23 %) |
| Mar 21 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 15.04 | 125,000 | 1,880,000 | 317,861 | 442.9 K to 317.9 K (-28.23 %) |
| Mar 21 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 15.23 | 154,039 | 2,346,014 | 442,861 | 596.9 K to 442.9 K (-25.81 %) |
| Mar 21 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 4.58 | 48,750 | 223,275 | 596,900 | 548.2 K to 596.9 K (+8.89 %) |
| Mar 21 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 2.78 | 18,622 | 51,769 | 548,150 | 529.5 K to 548.2 K (+3.52 %) |
| Mar 21 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 2.53 | 36,667 | 92,768 | 529,528 | 492.9 K to 529.5 K (+7.44 %) |
| Jan 06 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | A | 12.63 | 53,062 | 670,173 | 53,062 | |
| Jan 06 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 12.57 | 6,309 | 79,304 | 492,861 | 499.2 K to 492.9 K (-1.26 %) |
| Jan 06 2014 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 22,741 | 0 | 499,170 | 476.4 K to 499.2 K (+4.77 %) |
| Dec 31 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 12.64 | 30,000 | 379,200 | 476,429 | 506.4 K to 476.4 K (-5.92 %) |
| Dec 31 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | M | 4.59 | 30,000 | 137,700 | 506,429 | 476.4 K to 506.4 K (+6.30 %) |
| Dec 31 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 12.62 | 49,500 | 624,690 | 476,429 | 525.9 K to 476.4 K (-9.41 %) |
| Dec 31 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 12.68 | 30,000 | 380,400 | 525,929 | 555.9 K to 525.9 K (-5.40 %) |
| Oct 07 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 10.25 | 1,475 | 15,119 | 555,929 | 557.4 K to 555.9 K (-0.26 %) |
| Jul 09 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 7.95 | 1,438 | 11,432 | 557,404 | 558.8 K to 557.4 K (-0.26 %) |
| May 14 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 8.34 | 29,363 | 244,887 | 558,842 | 588.2 K to 558.8 K (-4.99 %) |
| Apr 08 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 6.93 | 1,484 | 10,284 | 588,205 | 589.7 K to 588.2 K (-0.25 %) |
| Jan 04 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | A | 2.78 | 55,866 | 155,307 | 55,866 | |
| Jan 04 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 2.74 | 10,859 | 29,754 | 589,689 | 600.5 K to 589.7 K (-1.81 %) |
| Jan 04 2013 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 33,520 | 0 | 600,548 | 567 K to 600.5 K (+5.91 %) |
| Oct 05 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 2.72 | 4,973 | 13,527 | 567,028 | 572 K to 567 K (-0.87 %) |
| Jul 06 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 1.99 | 4,559 | 9,072 | 572,001 | 576.6 K to 572 K (-0.79 %) |
| May 22 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 400,000 | 0 | 576,560 | 176.6 K to 576.6 K (+226.55 %) |
| Apr 05 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 1.60 | 5,458 | 8,738 | 176,560 | 182 K to 176.6 K (-3.00 %) |
| Jan 03 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | A | 2.53 | 55,000 | 139,150 | 55,000 | |
| Jan 03 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 2.63 | 7,190 | 18,874 | 182,018 | 189.2 K to 182 K (-3.80 %) |
| Jan 03 2012 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 28,000 | 0 | 189,208 | 161.2 K to 189.2 K (+17.37 %) |
| Oct 05 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 2.82 | 6,105 | 17,192 | 161,208 | 167.3 K to 161.2 K (-3.65 %) |
| Jul 07 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 4.80 | 4,611 | 22,133 | 167,313 | 171.9 K to 167.3 K (-2.68 %) |
| Jun 08 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 4.99 | 47,231 | 235,683 | 171,924 | 219.2 K to 171.9 K (-21.55 %) |
| Apr 07 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 5.10 | 4,490 | 22,899 | 219,155 | 223.6 K to 219.2 K (-2.01 %) |
| Jan 03 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Option Exercise | A | 4.58 | 48,750 | 223,275 | 48,750 | |
| Jan 03 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 4.67 | 14,064 | 65,679 | 223,645 | 237.7 K to 223.6 K (-5.92 %) |
| Jan 03 2011 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 16,250 | 0 | 237,709 | 221.5 K to 237.7 K (+7.34 %) |
| Dec 06 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 5.00 | 3,600 | 18,000 | 221,459 | 225.1 K to 221.5 K (-1.60 %) |
| Dec 06 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 5.06 | 24,150 | 122,199 | 225,059 | 249.2 K to 225.1 K (-9.69 %) |
| Dec 06 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 5.01 | 107,623 | 539,191 | 249,209 | 356.8 K to 249.2 K (-30.16 %) |
| Oct 06 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 4.58 | 1,209 | 5,537 | 356,832 | 358 K to 356.8 K (-0.34 %) |
| Aug 20 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 3.84 | 10,000 | 38,400 | 358,041 | 368 K to 358 K (-2.72 %) |
| Jan 05 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | S | 2.60 | 22,981 | 59,771 | 439,983 | 417 K to 440 K (+5.51 %) |
| Jan 05 2010 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 462,964 | 363 K to 463 K (+27.55 %) |
| Jun 23 2009 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Buy | P | 0.90 | 2,750 | 2,472 | 357,750 | 355 K to 357.8 K (+0.77 %) |
| Jan 06 2009 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Vice President, Fin ... | Grant | A | 0.00 | 50,000 | 0 | 330,000 | 280 K to 330 K (+17.86 %) |
| Aug 18 2008 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Vice President Fina ... | Grant | A | 0.00 | 280,000 | 0 | 280,000 | 0 to 280 K |
Page: 1